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Abstract
Background
Wasting and stunting are global public health problems that frequently co-exist. However,
they are usually separated in terms of policy, guidance, programming and financing.
Though both wasting and stunting are manifestations of undernutrition caused by disease
and poor diet, there are critical gaps in our understanding of the physiological relationship
between them, and how interventions for one may affect the other. The aim of this exercise
was to establish research priorities in the relationships between wasting and stunting to
guide future research investments.
Methods and Findings
We used the CHNRI (Child Health and Nutrition Research Initiative) methodology for setting
research priorities in health. We utilised a group of experts in nutrition, growth and child
health to prioritise 30 research questions against three criteria (answerability, usefulness
and impact) using an online survey. Eighteen of 25 (72%) experts took part and prioritised
research directly related to programming, particularly at the public health level. The highest-
rated questions were: “Can interventions outside of the 1000 days, e.g. pre-school, school
age and adolescence, lead to catch-up in height and in other developmental markers?”;
“What timely interventions work to mitigate seasonal peaks in both wasting and stunting?”;
and “What is the optimal formulation of ready-to-use foods to promote optimal ponderal
growth and also support linear growth during and after recovery from severe acute malnutri-
tion?” There was a high level of agreement between experts, particularly for the highest
ranking questions.
Conclusions
Increased commitment to rigorous evaluations of treatment and prevention interventions at
the public health level, addressing questions of the timing of intervention, and the extent to
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Introduction
Wasting and stunting are priority global public health problems. It is estimated that wasting
affects 52 million children (19 million with severe wasting) and stunting affects 165 million
children under five.[1] Each year, approximately 800,000 deaths are attributed to wasting (60%
of which are attributable to severe wasting) and over one million to stunting.[2] Wasting and
stunting are also associated with the loss of 64.6 and 54.9 million Disability Adjusted Life Years
(DALYs) respectively, accounting for 14.8% and 12.6% of the total global DALYs for children
under five.[3]
Globally, improvements in levels of stunting and wasting have been achieved. The preva-
lence of global under-five stunting has decreased from 40% in 1990 to 32% in 2005 to 25% in
2011. The greatest gains have been made in Asia, where stunting prevalence is highest (from
188.7 million in 1990 to 98.4 million in 2010), and in Latin America and the Caribbean (13.7
million in 1990 to 7.4 million in 2010).[2] The global prevalence of wasting in under-fives has
also decreased over the last twenty years, by 11% since 1990. Again, the highest prevalence of
wasting is in Asia, where 70% of the world’s wasted children live. However, in spite of these
recent gains, projections show that the current World Health Assembly (WHA) wasting and
stunting targets will not be met at the current rate of improvement.[4, 5]
The Lancet’s Maternal and Child Nutrition series in 2008[3] and 2013[2] identified a num-
ber of evidence-based specific nutrition interventions focusing both on treatment and preven-
tion of some of the immediate and underlying causes of undernutrition, which if scaled up
could reduce undernutrition-related mortality and disease burden by an estimated 25% in the
short term. Increased attention to nutrition sensitive interventions that aim to prevent under-
nutrition by targeting basic and underlying causes was highlighted as a priority to meet global
nutrition targets. A recent paper on the WHO 2025 stunting targets also highlights the need
for nutrition-sensitive development, and the development of multi-sectoral plans to address
stunting at national scale, as well as an accountability framework and surveillance systems to
monitor progress.[5] This policy direction has been taken on by the Scaling Up Nutrition
(SUN) movement as well as other global programmes and research and financing initiatives.
In parallel to these developments, a number of reviews[6–10] have highlighted the separa-
tion between wasting and stunting in the architecture of nutrition at policy, financing, pro-
gramme and research levels and suggested that addressing this separation may also be
important to achieving global nutrition targets.
“The fragmentation of interests and perspectives on childhood undernutrition has negative
consequences for advocacy efforts that aim to bring attention and resources to child nutri-
tion across the globe. It also has serious implications for how children worldwide receive
nutrition interventions and services.” (Menon & Stoltzfus, 2012)7
Both stunting and wasting are present in the majority of developing countries and contexts
(something also highlighted in the 2014 Global Nutrition Report);[5] can occur concurrently
in the same child (highlighted in the 2015 Global Nutrition Report);[11] and share underlying
and basic causal factors such as infectious diseases, environmental enteric dysfunction, a diet
with inadequate nutrients, and suboptimal infant feeding and caring practices. As a result,
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there is a need for the international community to look more closely at the way children experi-
ence these two manifestations of undernutrition over time, and focus programming (particularly
prevention approaches) and research more coherently towards achieving impacts for both.
This exercise aims to inform the research agenda of governments, researchers, donors, inter-
national agencies and national agencies about questions that are most likely to result in high
impact policies and practices that address the links between wasting and stunting.
Ethics statement
As is standard for CHNRI projects, formal ethics review was not needed since the work does
not involve any personal or otherwise sensitive data and works with professional participants
rather than patients. Participants were solicited via established professional networks, whose
key purpose is to facilitate and enable information-sharing and ‘group activities—such as
CHRNI. Participants were aware that their responses would be used for research. Those who
completed the questionnaire were asked whether they were happy to be named as part of the
‘MAMI group author’ list and only those answering “yes” are listed. Individual answers to the
questions are not presented and are anonymous.
Methods
We used the Child Health and Nutrition Research Initiative (CHNRI) methodology for setting
research priorities in health, described in detail elsewhere.[12–15] This is a well-recognised and
tested methodology for setting research priorities that enables the systematic and transparent
development, listing and scoring of possible research questions against pre-defined criteria.[16] It
enables individual experts to weigh up the strengths and weaknesses of research options and, as a
group, to produce a list of research questions in which investments should be prioritised. The
results have the potential to provide a powerful advocacy tool for investment in research from
international agencies, research funding bodies, donors, governments and policy-makers.[15]
We first defined the context and criteria for priority setting, displayed in Box 1. We agreed
to use an existing Technical Interest Group (TIG) facilitated by ENN as the expert group. The
Box 1. Context and criteria of the CHNRI exercise on wasting and
stunting.
Burden of disease of interest:Wasting affects 52 million (19 million severe wasting) and
stunting 165 million under 5’s each year. Estimates for the deaths attributable to wasting
based on these prevalence figures is 875,000/yr (516,000 of these are attributable to severe
wasting) and for stunting 1 million (15% of overall chid deaths). Stunting is associated
with 54.9 million DALYs (12.6% of the total global DALYs for children under 5) and
Wasting with 64.6 million DALYs (14.8% of the total global DALYs for children under
5).
Population of interest: All developing countries with a burden of stunting and wast-
ing, individuals within the 1000 days and beyond.
Existing policy/target:WHA targets: Wasting—reduce and maintain prevalence of
childhood wasting to<5%, Stunting—Reduce by 40% the number of under-five children
who are stunted. Level of urgency: The level of urgency is always high where there is an
elevated risk of excess infant and child mortality associated with wasting and stunting.
Time frame: To achieve measurable improvements in the burden of wasting and
stunting within 5 years.
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TIG had been set up at the beginning of 2014 to guide and contribute to a review of the rela-
tionship between wasting and stunting. It is made up of 25 individuals with extensive experi-
ence in research and programming for wasting and stunting and represents expertise with
different perspectives from a range of academic institutions, UN bodies, donors and NGOs.
The TIG identified possible research questions during the process of reviewing and discussing
the relationship between wasting and stunting in 2014 through email and face to face
exchanges.[10]
CHNRI methodology recognises that the number of possible health research options is
“endless and limited only by imagination of all living researchers”. It is not therefore possible
to achieve a list of all possible options, however, to achieve the widest possible list of options,
CHNRI methodology recommends the use of a theoretical framework to consider possible
options against. A smaller group of TIG members, including the authors of this paper, took the
list of possible research questions proposed by the wider group and placed them within the rec-
ommended theoretical framework. Questions were refined according to this framework and
resulted in a list of 30 possible options. The list of 30 options located within the CHNRI theo-
retical framework is described in Table 1.
CHNRI recommends a set of defined criteria with which to judge each of the research ques-
tions. We took the five basic criteria recommended in CHNRI methodology and, as recom-
mended in the CHNRI guidelines, for the sake of simplicity, merged “effectiveness” and
“deliverability” into one criterion named “usefulness”, and the criteria “maximum potential for
disease burden reduction” and “effect on equity” into one criterion named “impact”.[15] We
felt that it was important that the exercise was as straight forward and simple as possible, with-
out compromising on its usefulness, in order to encourage as many experts as possible to com-
plete the survey. Reducing the criteria to three allowed us to do this, and was explained to the
expert participants to aid common interpretation of the criteria. We used the following defini-
tions for each of the criteria:
1. Answerability: answerability of the research question (i.e. is it well framed, with well-defined
end points and is it likely to gain ethical approval?)
2. Usefulness: usefulness of answering the research question (i.e. would the intervention that
would be developed/ improved as a result of the research be deliverable, effective and
efficacious?)
3. Impact: Would the successful reaching of research endpoints for this question have high
impact (i.e. have the capacity to remove 5% or more of the disease burden, and be likely to
most benefit the most underprivileged?)
Experts were asked to envision what future interventions arising from each research ques-
tion might be in order to assess both the usefulness and impact of the specific research ques-
tion. The team did not feel that further guidance for each of the criteria was required, being
relatively confident that experts were familiar with the CHNRI methodology and that, as a
result, there would not be too much heterogeneity in the way that criteria were applied to the
research questions.
The 30 research questions were tabled against each of the three criteria and thus a total of 90
queries formed the basis of an online survey (www.surveymonkey.com). The survey was
ordered so that the scorers judged all of the questions against each of the judging criteria in
turn. All members of the TIG were sent emails with a link to the online survey to invite them to
take part. These are included as ‘group authors’ at the end of the paper.
Experts answered the questions listed in Table 1 by selecting either ‘Yes’ (valued as 1 point),
‘No’ (0 points), ‘Undecided’ (0.5 points) or ‘Insufficiently informed’ (defined as ‘missing
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Table 1. List of research questions located in the research framework.
Measuring the burden of wasting &
stunting
1. How to estimate incidence of wasting over time in different
contexts?
What is the global burden of children experiencing wasting
and stunting concurrently?
What are the implications of the global burden of concurrent
wasting and stunting on the global burden of mortality?
What is the global burden of severe stunting?
What are the implications of the global burden of severe
stunting on mortality burden?
How do wasting and stunting develop and interplay in
individuals over time?
Understanding risk factors for
wasting & stunting
2. What is the role of pre-pregnancy nutritional status in
determining risk of being born stunted and/or wasted?
Does foetal growth (in terms of timing of deﬁcits in ponderal
and/or linear growth) predict wasting and stunting?
Does anthropometric status at birth (in terms of ponderal
and/or linear growth) predict wasting and stunting in
childhood?
Does the process of stunting (slowing of linear growth) or
wasting (loss of weight) carry greater risks for a child
compared to the end point of being stunted or wasted in
relation to the growth reference?
What role does gut health/inﬂammation play in wasting?
What are the long-term implications of wasting and stunting
(separately and combined) in early life on adult health.
Evaluating existing interventions 3. What are the implications of rapid weight gain (as during
wasting treatment) on body composition and function in
childhood?
What are the implications of rapid weight gain (as during
wasting treatment) on body composition and function in
adulthood?
Does treatment of wasting support catch-up in linear
growth?
Basic research to develop or
improve interventions
4. What are the physiological/functional changes which occur
during wasting and stunting and when both are underway
concurrently?
How does body proportion and composition change during
wasting and stunting, in particular muscle and fat mass?
At what level of wasting does linear growth slow down or
speed up?
Does mid-upper arm circumference (MUAC) preferentially
identify children for treatment who have lower weight-for-
height and height-for-age in different contexts?
Clinical research to develop or
improve interventions
5. What is the optimal formulation of RUTF to promote optimal
ponderal growth and also support linear growth during and
after SAM recovery?
Can nutrition convalescent support (e.g. provision of
nutritional supplements & support triggered by a drop in
weight-for-height or weight-for-age after acute illness),
prevent both wasting and stunting?
What existing interventions work for treating severe stunting
in order to prevent associated mortality?
What new interventions work in trial conditions for treating
severe stunting in order to prevent associated mortality?
(Continued)
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input’). Each of the 30 research options received three scores, one for each criterion, each rang-
ing between 0% and 100%. The overall research priority score (RPS) was calculated as the
mean of all three priority scores and the priority of research questions were ranked
accordingly.
The ‘Average Expert Agreement’ score (AEA) was also computed, as recommended by
CHNRI.[15] The AEA provides a measure of the level of agreement or controversy between
expert scores in the answer given. This was calculated for each research option in our survey as
follows [14]:
AEA ¼ 1
9
X9
q¼1
Nðscores providing the most frequent responseÞ
Nðscores providing any responseÞ ð1Þ
(where q is a question that experts are being asked to evaluate competing research investment
options, ranging from 1 to 3).
Some CHNRI surveys have applied weightings to the different judging criteria used, accord-
ing to the values of a wider group of stakeholders, however, the majority of CHNRI exercises
have omitted this step. We decided to also omit this stage as we felt that the three criteria were
equally important.
Findings
Eighteen (72%) of the 25 TIG members took part in the survey. Sixteen completed the survey
in full. Respondents were from a mix of academic institutions, NGOs and UN agencies. Most
were academics (N = 10), some were engaged in operations/programming (N = 3), one was
engaged primarily in policy and others declared their involvement in a mix of these activities
(N = 4).
The range of overall research priority score (RPS) was 46.7 to 91.1, and for the top 25 ques-
tions, RPS ranged from 69.8 to 91.1. Table 2 shows the top ten ranked research questions. The
highest ranking research question was “Can interventions outside of the 1000 days, e.g. pre-
school, school age and adolescence, lead to catch-up in height and in other developmental
markers?” This question scored very highly against all three judging criteria. The second
highest scoring question was, “What timely interventions work to mitigate seasonal peaks in
undernutrition (both wasting and stunting)?” which scored particularly highly against
Table 1. (Continued)
Public Health research to develop or
improve interventions
6. Can interventions outside of the 1000 days, e.g. pre-school,
school age and adolescence, lead to catch-up in height and
in other developmental markers?
What existing interventions work for stunting reduction?
What new interventions work in trial conditions for stunting
reduction?
What timely interventions work to mitigate seasonal peaks in
undernutrition (both wasting and stunting)?
What are effective packages of interventions for both
maternal nutrition and new-born outcomes?
How can pre-pregnancy nutrition support for adolescent girls
be effectively and appropriately delivered?
What practical linkages between interventions to treat and
prevent wasting and stunting will have the highest impact?
(e.g. referral systems between programmes, carrying out
mid-upper arm circumference (MUAC) checks at routine
points of contact, etc.)
doi:10.1371/journal.pone.0153221.t001
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‘answerability’. The third highest ranking question was, “What is the optimal formulation of
RUTF to promote optimal ponderal growth and also support linear growth during and after
SAM recovery?” which scored particularly highly against the criteria ‘usefulness’. The fourth
highest ranked question was “What is the role of pre-pregnancy nutritional status in determin-
ing risk of being born stunted and/or wasted?” The fifth highest was, “What are effective pack-
ages of interventions for both maternal nutrition and new-born outcomes?”
All of the top three questions were categorised under the research instrument ‘research for
the development of new interventions/to improve existing interventions’, as indeed were eight
out of the top ten research questions. This demonstrated the group prioritised research that
directly relates to programming and public health, rather than epidemiological research. Most
would involve testing interventions at the public health level, such as interventions outside of
the first 1000 days (Q24), interventions to mitigate seasonal impacts (Q27), interventions that
use Ready-to-Use Foods (Q20), improved nutritional convalescent support (Q21) and identify-
ing synergies between interventions (Q28 and Q30).
The average expert agreement score (AEA) ranged from 0.42 to 0.85 overall, with the top
ten scoring questions having a high AEA (>0.7), and progressively less agreement amongst
lower scoring questions (Fig 1, linear regression of AEA against rps, P<0.001). Lower AEA was
observed for questions with a modal response of 0, indicating that no questions were univer-
sally rejected by the expert panel, perhaps reflecting the pre-screening of questions. However,
this also reflects less agreement about what not to study from the 30 selected questions, which
is a typical pattern seen with CHNRI studies, reflecting the different interests of the expert
participants.
Importantly, this group of experts agree that the top six research questions should be given
the greatest priority (with the highest level of agreement being for question 20, “What is the
optimal formulation of RUTF to promote optimal ponderal growth and also support linear
growth during and after SAM recovery?”, ranked third by RPS).
Table 2. Top ten questions ranked by RPS.
Question Rank Question
no.
Answerability Usefulness Impact RPS AEA
Can interventions outside of the 1000 days lead to catch-up in height
and in other developmental markers?
1 24 93.8 93.8 85.7 91.1 0.84
What timely interventions work to mitigate seasonal peaks in
undernutrition (both wasting and stunting)?
2 27 93.3 86.7 86.7 88.9 0.80
What is the optimal formulation of RUTF to promote optimal ponderal
growth and also support linear growth during and after SAM
recovery?
3 20 84.4 93.8 83.3 87.2 0.85
What is the role of pre-pregnancy nutritional status in determining
risk of being born stunted and/or wasted?
4 7 88.2 86.7 85.7 86.9 0.82
What are effective packages of interventions for both maternal
nutrition and new-born outcomes?
5 28 93.3 90.6 75.0 86.3 0.79
Can nutrition convalescent support prevent both wasting and
stunting?
6 21 89.3 90.6 73.3 84.4 0.79
What practical linkages between interventions to treat and prevent
wasting and stunting will have the highest impact?
7 30 78.1 90.6 83.3 84.0 0.74
What new interventions work in trial conditions for treating severe
stunting in order to prevent associated mortality?
8 23 71.9 87.5 89.3 82.9 0.74
What role does gut health/inﬂammation play in wasting? 9 11 81.3 90.6 76.7 82.8 0.72
Does treatment of wasting support catch-up in linear growth? 10 5 86.1 78.1 80.0 81.4 0.77
doi:10.1371/journal.pone.0153221.t002
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Discussion
This CHNRI research prioritisation exercise shows that research that directly relates to inter-
ventions and programming, rather than purely observational research, should be prioritised.
This prioritisation reflects the complexity of underlying and proximate causes of wasting and
stunting, meaning that outcomes cannot necessarily be predicted from simply observational
research. Taking this forward will require increased commitment from funders, academics and
implementing agencies to undertake clinical trials or large-scale programmatic evaluations that
are rigorous in design, with appropriate sample size, choice of comparator groups and follow
up for meaningful health outcomes.
The highest-rated question, “Can interventions outside of the 1000 days, e.g. pre-school,
school age and adolescence, lead to catch-up in height and in other developmental markers?”
arises from evidence of opportunities for catch-up growth in older age groups (i.e. outside the
first 1000 days) particularly during adolescence.[17] It is an area that has had little focus but
could have important implications, particularly in the case of adolescent girls, as evidence
shows that maternal stature may be a predictor of her child’s size at birth.[2] The timing of
interventions to promote catch up growth in mid-childhood and adolescence is not well under-
stood but may be important; studies of immigrant populations have shown that childhood
catch up growth can increase risk of early pubertal development, which can abbreviate the
childhood growth period and limit final height.[18] Though the 1000 days message has been
an important one to galvanise action, the group identified further investigation of these other
lifecycle opportunities, particularly supporting adolescent growth, as potentially key for meet-
ing undernutrition targets. Though the question of the timing of catch-up from stunting refers
Fig 1. Scatterplot of AEA vs. RPS for all questions, with the top 10 by RPS shown in red.
doi:10.1371/journal.pone.0153221.g001
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specifically to stunting, rather than to the relationship between stunting and wasting, it was not
surprising to the authors that it received top ranking. The question of different age target
groups for wasting (<5’s) and stunting (<2’s) programming was at the time the subject of a
number of high profile articles and debates at conferences as well as within the TIG, and is crit-
ical to programming.
The second question, “what timely interventions work to mitigate seasonal peaks in under-
nutrition (both wasting and stunting)?” relates to strong seasonal patterns of stunting and
wasting, illustrated in a number of countries.[19, 20] These patterns may be linked to seasonal-
ity in the causal factors and/or may even illustrate a degree of direct correlation between wast-
ing and stunting–this is an area where many questions still remain unanswered. However,
recent trials, such as the provision of seasonal nutritional supplementation in Niger,[21] have
shown effects on both wasting and stunting. Further studies are underway in this area, includ-
ing into the role of cash and/or voucher transfers in preventing seasonal increases in wasting.
[22] The prioritisation of this question is a call for future studies to measure effects on both
stunting and wasting.
The third question, “what is the optimal formulation of RUTF to promote optimal ponderal
growth and also support linear growth during and after SAM recovery?” is underpinned by the
fact that only a few studies of SAM or MAM treatment have looked at linear growth during or
after treatment, or compared different formulations of RUTF in trials of adequate size. Those
studies that have suggest that there is no positive effect of RUTF based treatments on linear
growth outcomes. [10, 23] However, there is some evidence that linear growth ceases or slows
during periods of wasting[24–27] and therefore, the timing of restarting of linear growth and
how this might be supported during wasting treatment is an area deemed important for more
focussed research.
The fourth and fifth questions, “what is the role of pre-pregnancy nutritional status in deter-
mining risk of being born stunted and/or wasted?” and “what are effective packages of inter-
ventions for both maternal nutrition and new-born outcomes?” relate to the highest-rated
question. There is some evidence that suggests that pre-pregnancy maternal nutritional status
in terms of stature, BMI, and micronutrient status, may play a role in determining length and
weight at birth.[2] This does not negate the need to support maternal nutrition during preg-
nancy but suggests that they may be important opportunities to support nutrition pre-preg-
nancy that are not currently being capitalised on. The intergenerational cycle of growth failure
links small maternal size back to mothers’ growth in childhood and adolescence and even back
to her own size at birth. This suggests that pre-pregnancy nutritional status may be extremely
important for determining the risk of a child being born with linear and/or ponderal growth
deficits. Therefore, there is increasingly a call for focus on pre-conceptional interventions for
improving maternal pre-pregnancy BMI, and interventions that can influence linear growth
and attained adult height in order to benefit foetal growth.[28] Further investigating the origins
of wasting and stunting could help to strengthen support for maternal nutrition, and help pro-
grammers to expand their windows of opportunity to break the intergenerational cycle of
undernutrition.
In general, there remains a critical need for clinical trials and evaluation to be conducted rig-
orously in programmatic contexts, with adequate sample sizes and standardised designs that
assess outcomes both for wasting and stunting in order to identify the potential for approaches
to influence both public health problems. In a recent review of trials of supplementary feeding
interventions, the considerable heterogeneity between studies made it difficult to draw firm
conclusions.[29] These considerations also apply to more development-oriented approaches,
such as positive deviance/hearth or water and sanitation interventions, where designs, method-
ological quality and results have been variable.[30, 31]
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Increasingly, the focus of international nutrition is on multi-sectoral interventions (involv-
ing health education, agriculture, social, political and environmental actors in both the human-
itarian and development domains), particularly for the prevention of undernutrition. The
more such multi-sectoral approaches can be assessed in terms of impact on both stunting and
wasting, the better their contribution to achieving country and global nutrition targets can be
evaluated.
Strengths and limitations
The CHNRI methodology proved to be a helpful tool for systematically listing and scoring spe-
cific research questions in a transparent way against specific criteria. It allowed experts to score
questions independently of each other and therefore limited the influence of individuals that
might express strong opinions in a group setting. The CHNRI methodology also generated
quantitative outputs that were relatively easy for the group to interpret, including clearly
ranked research priorities, and a measure of the questions that cause the greatest agreement
and controversy.
Our study has some weaknesses. A relatively small number of experts were engaged in the
process of setting research questions (N = 25) and an even smaller number in the priority set-
ting exercise (N = 18). This may expose the results to the biases of this particular group (e.g.
most respondents were academics fromWestern institutions) and may mean that scores are
not stable. However, the pool of experts in this area globally is relatively small, and a high level
of engagement was required for both the review and research prioritisation, which made it dif-
ficult to recruit a larger number of individuals into the TIG. Results can be seen as a useful
guide for research investments in this important area nonetheless. Furthermore, not all possible
research options were included in the study, nor could they be whilst maintaining a feasible
methodology. In future, other research options, not included here, are likely to arise given the
interest in this area and rapidly emerging evidence on stunting in particular. This limits the
applicability of these results as time passes. In this case, a repetition of the exercise would be
required. In addition, the research options considered were those that would be likely to
achieve impact on the burden of wasting and stunting within five years (Box 1). This may have
influenced the type of research options chosen by limiting research options that would take a
longer time to deliver results. We chose to limit the potential scope of studies in this way in
order to maintain focus to the exercise, but also given that this is a realistic time frame to expect
research donors to fund. Finally, as we decided to omit the stage of the CHNRI process that
applies weightings to each of the judging criteria based on a wider set of societal values, as we
felt all criteria were of equal importance. We therefore perhaps missed an opportunity to
engage a wider audience and to reflect societal values in the results of the study. Nevertheless,
we believe these results to be an important guide in the selection of research options for
investment.
Conclusions
The need to reduce current levels of wasting and stunting is compelling and is reflected in the
WHA targets and in the emerging SDGs. There is unprecedented global momentum to drive
levels of undernutrition down and many country governments are putting in place policies and
programmes to achieve these reductions. However, the current degree of separation between
wasting and stunting policy, guidance, programming and financing, may hinder the pace of
change required and the evidence, though weak, does suggest that preventative approaches
should target both forms of undernutrition simultaneously. New evidence, especially for stunt-
ing, is rapidly emerging, thus the CHNRI process is likely to need updating over time, as in
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other research areas. High priority research questions are currently those that trial or study
interventions, mostly (though not exclusively) at the public health level that can inform the
appropriate timing of treatment and prevention interventions and the extent to which impacts
for both wasting and stunting can be achieved. As in other fields related to child development,
health and survival, it is essential that high quality evidence from rigorous evaluations is gener-
ated in order to inform global efforts to tackle the ongoing high burdens of wasting and
stunting.
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